|
1
|
Howlader N, Noone AM, Krapcho M, Miller D,
Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al:
SEER cancer statistics review, 1975–2017. National Cancer
Institute; Bethesda, MD: 2020, https://seer.cancer.gov/csr/1975_2017/
|
|
2
|
Polyak K: Heterogeneity in breast cancer.
J Clin Invest. 121:3786–3788. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yedjou CG, Sims JN, Miele L, Noubissi F,
Lowe L, Fonseca DD, Alo RA, Payton M and Tchounwou PB: Health and
racial disparity in breast cancer. Adv Exp Med Biol. 1152:31–49.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chlebowski RT, Chen Z, Anderson GL, Rohan
T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell
FA, et al: Ethnicity and breast cancer: Factors influencing
differences in incidence and outcome. J Natl Cancer Inst.
97:439–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koboldt DC, Fulton RS, McLellan MD,
Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ,
Ding J, Mardis ER, et al: Comprehensive molecular portraits of
human breast tumours. Nature. 490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carrot-Zhang J, Chambwe N, Damrauer JS,
Knijnenburg TA, Robertson AG, Yau C, Zhou W, Berger AC, Huang KL,
Newberg JY, et al: Comprehensive analysis of genetic ancestry and
its molecular correlates in cancer. Cancer Cell. 37:639–654.e6.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huo D, Hu H, Rhie SK, Gamazon ER,
Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Troester
M, et al: Comparison of breast cancer molecular features and
survival by african and european ancestry in the cancer genome
atlas. JAMA Oncol. 3:1654–1662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McLaren W, Gil L, Hunt SE, Riat HS,
Ritchie GR, Thormann A, Flicek P and Cunningham F: The ensembl
variant effect predictor. Genome Biol. 17:1222016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mayakonda A, Lin DC, Assenov Y, Plass C
and Koeffler HP: Maftools: Efficient and comprehensive analysis of
somatic variants in cancer. Genome Res. 28:1747–1756. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ge SX, Jung D and Yao R: ShinyGO: A
graphical gene-set enrichment tool for animals and plants.
Bioinformatics. 36:2628–2629. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liberzon A, Subramanian A, Pinchback R,
Thorvaldsdóttir H, Tamayo P and Mesirov JP: Molecular signatures
database (MSigDB) 3.0. Bioinformatics. 27:1739–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vaser R, Adusumalli S, Leng SN, Sikic M
and Ng PC: SIFT missense predictions for genomes. Nat Protoc.
11:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Köhler S, Gargano M, Matentzoglu N,
Carmody LC, Lewis-Smith D, Vasilevsky NA, Danis D, Balagura G,
Baynam G, Brower AM, et al: The human phenotype ontology in 2021.
Nucleic Acids Res. 49(D1): D1207–D1217. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sondka Z, Bamford S, Cole CG, Ward SA,
Dunham I and Forbes SA: The COSMIC cancer gene census: Describing
genetic dysfunction across all human cancers. Nat Rev Cancer.
18:696–705. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keenan T, Moy B, Mroz EA, Ross K,
Niemierko A, Rocco JW, Isakoff S, Ellisen LW and Bardia A:
Comparison of the genomic landscape between primary breast cancer
in African American versus white women and the association of
racial differences with tumor recurrence. J Clin Oncol.
33:3621–3627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Olivier M, Hollstein M and Hainaut P: TP53
mutations in human cancers: Origins, consequences, and clinical
use. Cold Spring Harb Perspect Biol. 2:a0010082010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roberts SA, Lawrence MS, Klimczak LJ,
Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL,
Saksena G, et al: An APOBEC cytidine deaminase mutagenesis pattern
is widespread in human cancers. Nat Genet. 45:970–976. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Burns MB, Lackey L, Carpenter MA, Rathore
A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N,
Nikas JB, et al: APOBEC3B is an enzymatic source of mutation in
breast cancer. Nature. 494:366–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanchez-Vega F, Mina M, Armenia J, Chatila
WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia
S, et al: Oncogenic signaling pathways in the cancer genome atlas.
Cell. 173:321–337.e10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lawrence MS, Stojanov P, Polak P, Kryukov
GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH,
Roberts SA, et al: Mutational heterogeneity in cancer and the
search for new cancer-associated genes. Nature. 499:214–218. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lawrence MS, Stojanov P, Mermel CH,
Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander
ES and Getz G: Discovery and saturation analysis of cancer genes
across 21 tumour types. Nature. 505:495–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang R, Yu Y, Zong X, Li X, Ma L and
Zheng Q: Monomethyltransferase SETD8 regulates breast cancer
metabolism via stabilizing hypoxia-inducible factor 1α. Cancer
Lett. 390:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paulsen RD, Soni DV, Wollman R, Hahn AT,
Yee MC, Guan A, Hesley JA, Miller SC, Cromwell EF, Solow-Cordero
DE, et al: A genome-wide siRNA screen reveals diverse cellular
processes and pathways that mediate genome stability. Mol Cell.
35:228–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo H, Chen W, Ming J, Zhong R, Yi P, Zhu
B, Miao X and Huang T: Association between polymorphisms in cdc27
and breast cancer in a Chinese population. Tumour Biol.
36:5299–5304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Talvinen K, Karra H, Pitkänen R, Ahonen I,
Nykänen M, Lintunen M, Söderström M, Kuopio T and Kronqvist P: Low
cdc27 and high securin expression predict short survival for breast
cancer patients. APMIS. 121:945–953. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jackson SP and Bartek J: The DNA-damage
response in human biology and disease. Nature. 461:1071–1078. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andresen MS, Sletten M, Sandset PM,
Iversen N, Stavik B and Tinholt M: Coagulation factor V (F5) is an
estrogen-responsive gene in breast cancer cells. Thromb Haemost.
122:1288–1295. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tinholt M, Stavik B, Tekpli X, Garred Ø,
Borgen E, Kristensen V, Sahlberg KK, Sandset PM and Iversen N:
Coagulation factor V is a marker of tumor-infiltrating immune cells
in breast cancer. Oncoimmunology. 9:18246442020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Parkes EE, Walker SM, Taggart LE, McCabe
N, Knight LA, Wilkinson R, McCloskey KD, Buckley NE, Savage KI,
Salto-Tellez M, et al: Activation of STING-dependent innate immune
signaling by S-phase-specific DNA damage in breast cancer. J Natl
Cancer Inst. 109:djw1992016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Motwani M, Pesiridis S and Fitzgerald KA:
DNA sensing by the cGAS-STING pathway in health and disease. Nat
Rev Genet. 20:657–674. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cortes-Ciriano I, Lee S, Park WY, Kim TM
and Park PJ: A molecular portrait of microsatellite instability
across multiple cancers. Nat Commun. 8:151802017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vernochet C, Peres SB, Davis KE, McDonald
ME, Qiang L, Wang H, Scherer PE and Farmer SR: C/EBPalpha and the
corepressors CtBP1 and CtBP2 regulate repression of select visceral
white adipose genes during induction of the brown phenotype in
white adipocytes by peroxisome proliferator-activated receptor
gamma agonists. Mol Cell Biol. 29:4714–4728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim YI: Role of the MTHFR polymorphisms in
cancer risk modification and treatment. Future Oncol. 5:523–542.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sohn KJ, Croxford R, Yates Z, Lucock M and
Kim YI: Effect of the methylenetetrahydrofolate reductase C677T
polymorphism on chemosensitivity of colon and breast cancer cells
to 5-fluorouracil and methotrexate. J Natl Cancer Inst. 96:134–144.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guan Y, Xu B, Sui Y, Chen Z, Luan Y, Jiang
Y, Wei L, Long W, Zhao S, Han L, et al: Pan-cancer analysis and
validation reveals that D-dimer-related genes are prognostic and
downregulate CD8+ T cells via TGF-Beta signaling in
gastric cancer. Front Mol Biosci. 9:7907062022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tan Z, Gao L and Wang Y, Xu J and Wang Y:
PRSS contributes to cetuximab resistance in colorectal cancer. Sci
Adv. 6:eaax55762020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weiss FU: Pancreatic cancer risk in
hereditary pancreatitis. Front Physiol. 5:702014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Milite C, Feoli A, Viviano M, Rescigno D,
Cianciulli A, Balzano AL, Mai A, Castellano S and Sbardella G: The
emerging role of lysine methyltransferase SETD8 in human diseases.
Clin Epigenetics. 8:1022016. View Article : Google Scholar : PubMed/NCBI
|
